Track topics on Twitter Track topics that are important to you
22 Firstfield Road, Suite 250
United States of America
Fax: (301) 944-1703
The phase I clinical study will evaluate the safety of MaxCyte's MCY-M11 chimeric antigen receptor in people with relapsed or difficult-to-treat ovarian cancer and peritoneal mesothelioma
MaxCyte has received investigational new drug (IND) approval from the US Food and Drug Administration (FDA) to initiate a Phase...Read More... The post MaxCyte receives FDA approval to start Phase I s...
MaxCyte's first next-generation chimeric antigen receptor MCY-M11 will be studied in solid tumors.
MaxCyte, a global cell─based medicines and life sciences company, has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to begin a clinical study in th...
The US National Institutes of Health (NIH) has signed a cooperative research and development agreement (CRADA) with life sciences company...Read More... The post NIH and MaxCyte to develop new sickle ...
Its first CAR therapy will be tested in patients with ovarian cancer
The collaboration will be with National Heart, Lung and Blood Institute, which is part of the NIH
The US Food & Drug Administration has given the company investigational new drug clearance for MCY-M11, a chimeric antigen receptor that targets solid tumours
MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell the...
MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which bre...
MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...
We have published hundreds of MaxCyte, Inc news stories on BioPortfolio along with dozens of MaxCyte, Inc Clinical Trials and PubMed Articles about MaxCyte, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MaxCyte, Inc Companies in our database. You can also find out about relevant MaxCyte, Inc Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...